Overview
Neuros Life Sciences develops small-molecule therapeutics targeting neuroinflammation pathways to treat Alzheimer's disease and related dementias.
More in Neuropharmaceuticals
Latest industry news
Brain-Computer Interface Gives Unresponsive ICU Patients Auditory Control for the First Time
2026-10-23 · Research
China Moves to Standardise Brain-Computer Interface Technology, Reshaping Global Neurotech Governance
2026-10-22 · Policy
BCI Market Projected to Sustain 17.9% CAGR Through 2033 as Investment and Clinical Activity Accelerate
2026-10-21 · Industry
The Return of Ancient Spiritual Technology
2026-10-21 · Feature
Company details
Category
💊 Neuropharmaceuticals
Location
San Diego, CA
Funding
Series A — $42M
Website
neuroslifesciences.comListed
2026-08-03
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →